glp-1 agonist gastroparesis Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Gastroparesis: Symptoms, Causes, Diagnosis &

doi: 10.1007/s12028-023-01752-y 180 DAmatoSAChangTR

(Campone 2013) A large double-blind RCT (n=409) found no benefit of LC for CIPN prevention in breast cancer patients receiving taxanes

This reflects early changes in cell turnover rates

For instance, a specific RAND survey isn't publicly validated, but a 2024 poll by the American Medical Association estimates that about 16% of U.S

Prospective studies found that PCa patients with greater extent of intra prostatic inflammation exhibit poorer outcome [10, 11]

Currently, the modulation of intestinal microbiota through microecological therapies, including probiotics, prebiotics, and fecal microbiota transplantation, is a prominent area of clinical investigation for preventing and managing hyperuricemia and gout